This is a systematic review and meta-analysis comparing laparoscopic-guided transversus abdominis plane block (Lap-TAPB) to ultrasound-guided transversus abdominis plane block (US-TAPB) in patients undergoing laparoscopic colorectal surgery. The analysis synthesized data from 585 patients.
The authors found no significant difference between the two techniques for the primary outcome of 24-hour postoperative opioid consumption (SMD −0.16; 95% CI = −0.39 to 0.08, p = 0.20). Similarly, no significant differences were observed for pain scores at 24 hours at rest (SMD −0.17; 95% CI = −0.39 to 0.04, p = 0.12), incidence of postoperative nausea and vomiting (OR = 0.97; 95% CI = 0.36–2.65, p = 0.96), operative time (SMD 0.05; 95% CI = −0.19 to 0.30, p = 0.67), or complications (OR = 1.25; 95% CI = 0.77–2.03, p = 0.37).
The authors noted that previous meta-analyses were constrained by small sample sizes and lacked integration of emerging evidence from recent randomized controlled trials. Safety data, including adverse events, were not reported in the source.
The authors suggest that Lap-TAPB eliminates the need for ultrasound devices and may decrease logistical complexity. However, the findings are based on a synthesis of existing trials and do not establish superiority or equivalence definitively. Clinicians should interpret these results in the context of the available evidence, which indicates no clear advantage for either technique.
View Original Abstract ↓
BackgroundTransversus abdominis plane block (TAPB) has become a fundamental component of multimodal analgesia for laparoscopic colorectal surgery. Previous meta-analyses comparing laparoscopic-guided TAPB (Lap-TAPB) with ultrasound-guided TAPB (US-TAPB) were constrained by small sample sizes and lacked integration of emerging evidence from recent randomized controlled trials (RCTs). Given the increasing number of studies published since 2023, an updated review is warranted.ObjectivesTo conduct an updated systematic review and meta-analysis comparing Lap-TAPB with US-TAPB in terms of analgesic efficacy and perioperative outcomes in patients undergoing laparoscopic colorectal surgery.MethodsPubMed, Embase, and Web of Science were searched, from their inception until November 2025, for studies evaluating Lap-TAPB versus US-TAPB and reporting postoperative analgesic or clinical outcomes following the PRISMA guidelines. The primary outcome was 24-h postoperative opioid consumption, whereas the secondary outcomes included pain scores at 24 h (at rest), postoperative nausea and vomiting (PONV), operative time and complications.ResultsFive studies involving 585 patients were included in this review. No significant differences were observed in 24-h postoperative opioid consumption with Lap-TAPB (standardized mean difference (SMD) −0.16, 95% confidence interval (CI) = −0.39 to 0.08, p = 0.20), pain scores at rest at 24 h (SMD −0.17, 95% CI = −0.39 to 0.04, p = 0.12), incidence of PONV (odds ratio (OR) = 0.97, 95% CI = 0.36–2.65, p = 0.96), operative time (SMD 0.05, 95% CI = −0.19 to 0.30, p = 0.67), and complications (OR = 1.25, 95% CI = 0.77–2.03, p = 0.37).ConclusionLap-TAPB did not result in significantly lower 24-h postoperative opioid consumption, pain scores at 24 h (at rest), PONV incidence, operative time and complications compared to US-TAPB. However, it eliminates the need for ultrasound devices while decreasing the logistical complexity of the procedure.